Gender Dysphoria Clinical Trial
Official title:
The Strategic Use of Hyaluronic Acid Fillers and Neurotoxin to Influence Gender Perception in Transgender Individuals
Verified date | July 2020 |
Source | Mountain Dermatology Specialists |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Observational survey study of transgender individuals who have undergone cosmetic neurotoxin and soft tissue filler for the purpose of influencing gender perception.
Status | Completed |
Enrollment | 2 |
Est. completion date | July 15, 2020 |
Est. primary completion date | July 15, 2020 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility |
Inclusion Criteria: - Healthy male or female transgender volunteer - Has the desire to alter gender perception and is seeking treatment with neurotoxin and soft tissue filler - Subjects with an already existing treatment plan - Willing to sign photography release, with the understanding the de-identified photographs may be used in medical publications or presentations for the purposes of education - Females of childbearing potential who are sexually active are using a reliable method of contraception1 at least one month before the beginning of the study, and throughout the study - Must be informed about the study objectives and procedures, and be able to understand them - Willing and able to fulfill the study requirements and schedule - Willing to give their written informed consent Exclusion Criteria: - Individuals who underwent a neurotoxin procedure on the face within 6 months of study start - Individuals who underwent an injectable filler procedure on the face within 1 year of study start - Individuals who underwent surgical procedure on the face for the purpose of gender reassignment or cosmetic enhancement at any point in time before study start Individuals who have planned cosmetic treatments or surgeries during the course of the study - Individuals with dental procedures performed 30 days before, during, or 30 days after the course of the study - Individuals who participated within the 30 days before inclusion or currently participating in another clinical study involving the investigational areas - Individuals with known or suspected defect of healing - Individuals with any disease state or inappropriate physical skin condition that might impair evaluations or increase the health risk to the subject by participation in the opinion of the Investigator - Individuals unable to be contacted by phone in case of emergency - Individuals who are currently participating in any other clinical trial or have participated in any clinical trial involving the investigation area within 30 days prior to inclusion into the study. |
Country | Name | City | State |
---|---|---|---|
United States | Skin Care Physicians | Chestnut Hill | Massachusetts |
Lead Sponsor | Collaborator |
---|---|
Mountain Dermatology Specialists |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Self perceived gender perception | subject reported gender perception on a novel Self-perceived gender perception scale, before and after previously conducted cosmetic treatments. The scale exists on a spectrum of 100% male to 100% female in appearance. Pt will rate themselves along this scale in accordance with their physical appearance as it relates to self-perceived gender. | 4 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06098781 -
Gynaecological Gender-affirming Surgeries
|
||
Recruiting |
NCT04064671 -
ZEPHYR: A Study Evaluating Surgical Outcome After Implantation of the Zephyr ZSI 475 FTM Inflatable Penile Implant in the Neophallus After Female-to-male Sex Reassignment Surgery
|
||
Completed |
NCT03602222 -
An LGBT-Competency Program for Mental Health Professionals in Romania
|
N/A | |
Completed |
NCT04708600 -
Effectiveness of Speech Therapy in Trans Women.
|
N/A | |
Completed |
NCT04195659 -
Chest Dysphoria in Transmasculine Spectrum Adolescents
|
||
Not yet recruiting |
NCT05903911 -
Trans Care: An Online Intervention to Reduce Symptoms of Gender Dysphoria
|
N/A | |
Not yet recruiting |
NCT04160364 -
Gender Dysphoria in Children and Adolescents : Parents' Perspectives
|
||
Not yet recruiting |
NCT04265885 -
Gender Dysphoria and Transition
|
||
Recruiting |
NCT06245681 -
Effects of Cross-sex Hormone Treatment on Cardiac Function, Myocardial and Hepatic Fat Content
|
||
Active, not recruiting |
NCT05489159 -
Sleep and IR in Transgender Adolescents
|
||
Recruiting |
NCT04736797 -
Transition in Transgender
|
||
Recruiting |
NCT04979338 -
Development of Effective, Opioid Sparing Techniques for Peri-operative Pain Management of Transgender Patients Undergoing Gender Affirming Surgeries
|
Phase 3 | |
Recruiting |
NCT05829928 -
Testicular Tissue Cryopreservation in the Setting of Gender-Affirming Therapy
|
||
Recruiting |
NCT04993469 -
Patient Reported Outcome on Genital Sensitivity and Sexual Function After Genital Gender Affirming Surgery
|
N/A | |
Recruiting |
NCT05884307 -
Trans Care: An Online Intervention to Reduce Symptoms of Gender Dysphoria
|
N/A | |
Recruiting |
NCT05883553 -
Epithesis Versus Prosthesis in Post-phalloplasty Transgender Patients.
|
N/A | |
Completed |
NCT04290286 -
i2TransHealth: Interdisciplinary, Internet-based Trans Health Care
|
N/A | |
Terminated |
NCT03078829 -
The Relation of GnRH Treatment to QTc Interval in Transgender Females
|
||
Recruiting |
NCT05649605 -
Early Mental Response - The EMRE Study
|
N/A | |
Recruiting |
NCT05204732 -
Acoustic and Perceptual Effects of Intonation Training in Gender Diverse People
|
N/A |